Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.92 |
| ▸ | TSHR | P16473 | 1/20 | 0.92 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.69 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | KDM4A | O75164 | 5/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 5/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL31657059 | 1.00 | ALDH1A1 (0.92) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL13169236 | 0.96 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL1892890 | 0.96 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL8087077 | 0.96 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL8083762 | 0.96 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL7942101 | 0.96 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL35856 | 0.96 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL235238 | 0.96 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL8083779 | 0.96 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL1729138 | 0.96 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085221-A1 | CMP COMPOSITION INCLUDING ALCOHOL AMINE MOLYBDENUM ETCH INHIBITOR | ENTEGRIS INC (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260055307-A1 | LOW CORROSION HIGH REMOVAL RATE COMPOSITION FOR TUNGSTEN AND MOLYBDENUM CMP | ENTEGRIS INC (US) | 2026-02-26 | — | — | US | disclosed |
| US-20250304842-A1 | COMPOSITION FOR BIMETALLIC CMP | ENTEGRIS, INC. | 2025-10-02 | — | — | US | disclosed |
| US-20250223479-A1 | CMP SLURRY COMPOSITION FOR POLISHING TUNGSTEN AND METHOD FOR POLISHING TUNGSTEN USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2025-07-10 | — | — | US | disclosed |
| EP-3999605-B1 | METHOD TO INCREASE BARRIER FILM REMOVAL RATE IN BULK TUNGSTEN SLURRY | CMC MAT LLC (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-3116969-B1 | COMPOSITION FOR TUNGSTEN CMP | CMC MAT INC (US) | 2023-05-24 | — | — | EP | disclosed |
| US-11597854-B2 | Method to increase barrier film removal rate in bulk tungsten slurry | CMC MATERIALS, INC. (US) | 2023-03-07 | — | — | US | disclosed |
| EP-3116970-B1 | COMPOSITION FOR TUNGSTEN CMP | CMC MAT INC (US) | 2022-11-02 | — | — | EP | disclosed |
| EP-3161098-B1 | TUNGSTEN CHEMICAL-MECHANICAL POLISHING COMPOSITION | CMC MAT INC (US) | 2022-10-26 | — | — | EP | disclosed |
| EP-3999605-A1 | METHOD TO INCREASE BARRIER FILM REMOVAL RATE IN BULK TUNGSTEN SLURRY | CMC Materials, Inc. (US) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085221-A1 | CMP COMPOSITION INCLUDING ALCOHOL AMINE MOLYBDENUM ETCH INHIBITOR | TAAR1, CHRM1, CHRM2 | ALDH1A1 557/4885TSHR 703/4885DNM1 3611/4885 |
| US-20260055307-A1 | LOW CORROSION HIGH REMOVAL RATE COMPOSITION FOR TUNGSTEN AND MOLYBDENUM CMP | CHRM1, CHRM2, NPM1 | ALDH1A1 3701/4885TSHR 305/4885DNM1 4019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.